Similar articles

• Letter: Debrisoquine, guanethidine, and bethanidine in hypertension.

  Talbot S, O'Malley BC, Bing RH. Talbot S, et al. Br Med J. 1975 May 3;2(5965):278. doi: 10.1136/bmj.2.5965.278-b. Br Med J. 1975. PMID: 1131592 Free PMC article. Clinical Trial. No abstract available.
• Guanadrel and guanethidine in hypertension.

  Bloomfield DK, Cangiano JL. Bloomfield DK, et al. Clin Pharmacol Ther. 1970 Mar-Apr;11(2):200-4. doi: 10.1002/cpt1970112200. Clin Pharmacol Ther. 1970. PMID: 4906727 Clinical Trial. No abstract available.
• Medical management of primary hypertension. 3.

  Page LB, Sidd JJ. Page LB, et al. N Engl J Med. 1972 Nov 23;287(21):1074-81. doi: 10.1056/NEJM197211232872106. N Engl J Med. 1972. PMID: 4404062 Review. No abstract available.
• [Influence of guanethidine (ismelin) on the urinary excretion of noradrenaline in hypertensive patients].

  Rahn KH. Rahn KH. Verh Dtsch Ges Inn Med. 1971;77:116-8. Verh Dtsch Ges Inn Med. 1971. PMID: 5155810 German. No abstract available.
• Guanadrel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension.

  Finnerty FA Jr, Brogden RN. Finnerty FA Jr, et al. Drugs. 1985 Jul;30(1):22-31. doi: 10.2165/00003495-198530010-00005. Drugs. 1985. PMID: 3896742 Review.